Publisher
Springer Berlin Heidelberg
Reference10 articles.
1. Bonnefoi H, Smith IE, O’Brien MER et al (1996) Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-toler-ated outpatient regimen. Br J Cancer 73:391–396
2. Cameron DA, Gabra H, Leonhard RCF (1994) Continuous 5-fluorouracil in the treatment of breast cancer. Br J Cancer 70:120–124
3. Eisen T, Smith IE, Johnston S et al (1998) A randomised phase II trial of infusional 5-fluorouracil, epirubicin and cydophosphamide (ECycloF) versus infusional 5-fluorouracil, epirubicin and cisplatin (ECisF) in patients with advanced breast cancer. J Clin Oncol (in press)
4. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Corne S, Steele G, Frei E III (1978) A clinical pharmacologic evaluation of hepatic arterial infusion of 5-fluoro-2’-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784–3792
5. Huan S, Pazdur R, Singhakowinta A, Samal B, Vaikevicius V (1989) Low-dose continuous infusion 5-fluorouracil: evaluation in advanced breast cancer. Cancer 63:419–422
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献